Trump signs psychedelic research order

In a significant shift in federal drug policy, President Donald Trump signed an executive order to fast-track medical research into psychedelic substances.

The move specifically targets treatments for veterans suffering from post-traumatic stress disorder and traumatic brain injuries.

During the Oval Office signing, which included Joe Rogan and Health Secretary Robert F. Kennedy Jr., Trump joked about the substances while emphasizing their potential breakthrough status.

Critics have raised concerns about the safety risks associated with ibogaine, which remains in the government's most restrictive illegal drug category.